(Q53475847)

14 May 2018

title

Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal. (English)

1 reference

14 May 2018

author

Frank Gieseler

7

1 reference

14 May 2018

author name string

V Nüssler

1

1 reference

14 May 2018

R Pelka-Fleischer

2

1 reference

14 May 2018

H Zwierzina

3

1 reference

14 May 2018

C Nerl

4

1 reference

14 May 2018

B Beckert

5

1 reference

14 May 2018

E Gullis

6

1 reference

14 May 2018

S Bock

8

1 reference

14 May 2018

R Bartl

9

1 reference

14 May 2018

P E Petrides

10

1 reference

14 May 2018

publication date

1 January 1994

1 reference

14 May 2018

published in

Annals of Hematology

1 reference

14 May 2018

volume

69 Suppl 1

1 reference

14 May 2018

page(s)

S25-9

1 reference

14 May 2018

P-glycoprotein expression in locally advanced breast cancer treated by neoadjuvant chemotherapy

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01757351

Some monoclonal antibody reagents (C219 and JSB-1) to P-glycoprotein contain antibodies to blood group A carbohydrate determinants: a problem of quality control for immunohistochemical analysis

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01757351

Resistance modifying agents are active in some patients with hematological malignancy.

21 January 2018

1 reference

12 December 2020

Mdr1/P-glycoprotein expression in natural killer (NK) cells enriched from peripheral or umbilical cord blood

1 reference

12 December 2020

Multidrug resistance in haemopoietic cell lines, myelodysplastic syndromes and acute myeloblastic leukaemia.

1 reference

12 December 2020

Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies

1 reference

12 December 2020

Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells

1 reference

12 December 2020

Expression of a multidrug resistance gene in human cancers

1 reference

12 December 2020

Multidrug transport in human glioblastoma cells is inhibited by transforming growth factors type beta 1, beta 2, and beta 1.2.

1 reference

12 December 2020

The role of the MDR-1/P-170 mechanism in the development of multidrug resistance in chronic myeloid leukemia.

1 reference

12 December 2020

Comparative cellular pharmacology of daunorubicin and idarubicin in human multidrug-resistant leukemia cells

1 reference

12 December 2020

Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype

1 reference

12 December 2020

P-glycoprotein in acute nonlymphoblastic leukemia and in the blastic crisis of myeloid leukemia.

1 reference

12 December 2020

Monoclonal antibody to an external epitope of the human mdr1 P-glycoprotein.

1 reference

12 December 2020

Characterization of the human MDR3 P-glycoprotein and its recognition by P-glycoprotein-specific monoclonal antibodies

1 reference

12 December 2020

Detection of P-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies

1 reference

12 December 2020

Idarubicin monotherapy in multiply pretreated leukemia patients: response in relation to P-glycoprotein expression

1 reference

12 December 2020

Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine

1 reference

12 December 2020

Inhibition of cell proliferation, protein kinase C, and phorbol ester-induced fos expression by the dihydropyridine derivative B859-35.

1 reference

12 December 2020

Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01757351

1 reference

14 May 2018

1 reference

14 May 2018